Wesana Health Company Top Insiders
WSNAF Stock | USD 0 0 28.33% |
Wesana Health employs about 7 people. The company is managed by 7 executives with a total tenure of roughly 17 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Examination of Wesana Health's management performance can provide insight into the company performance.
Daniel Carcillo Insider CEO CoFounder |
Jeffrey Jewell Insider VP Affairs |
Wesana |
Wesana Health Management Team Effectiveness
The company has return on total asset (ROA) of (0.4236) % which means that it has lost $0.4236 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.7162) %, meaning that it generated substantial loss on money invested by shareholders. Wesana Health's management efficiency ratios could be used to measure how well Wesana Health manages its routine affairs as well as how well it operates its assets and liabilities.Wesana Health Workforce Comparison
Wesana Health Holdings is rated below average in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 256. Wesana Health holds roughly 7.0 in number of employees claiming about 2.73% of stocks in Biotechnology industry.
Wesana Health Holdings Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Wesana Health Holdings Price Series Summation is a cross summation of Wesana Health price series and its benchmark/peer.
Wesana Health Notable Stakeholders
A Wesana Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Wesana Health often face trade-offs trying to please all of them. Wesana Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Wesana Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Daniel Carcillo | CEO CoFounder | Profile | |
Jeffrey Jewell | VP Affairs | Profile | |
Zed Wang | CFO Sec | Profile | |
Mark Wingertzahn | Chief Officer | Profile | |
Chad Bronstein | CoFounder | Profile | |
Keenan Gentry | VP Devel | Profile | |
Izzy Forman | VP Communications | Profile |
About Wesana Health Management Performance
The success or failure of an entity such as Wesana Health Holdings often depends on how effective the management is. Wesana Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Wesana management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Wesana management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Wesana Health Holdings Inc, a life sciences company, engages in the development and delivery of psychedelic medicines and psilocybin-assisted psychotherapies to treat traumatic brain injuries. It is developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological, and mental health ailments caused by trauma. Wesana Health operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Wesana Health Workforce Analysis
Traditionally, organizations such as Wesana Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Wesana Health within its industry.Wesana Health Manpower Efficiency
Return on Wesana Health Manpower
Revenue Per Employee | 38.2K | |
Revenue Per Executive | 38.2K | |
Net Loss Per Employee | 4.9M | |
Net Loss Per Executive | 4.9M |
Complementary Tools for Wesana Pink Sheet analysis
When running Wesana Health's price analysis, check to measure Wesana Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Wesana Health is operating at the current time. Most of Wesana Health's value examination focuses on studying past and present price action to predict the probability of Wesana Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Wesana Health's price. Additionally, you may evaluate how the addition of Wesana Health to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |